Non-occupational malignant pleural mesothelioma due to asbestos and non-asbestos fibres


The occurrence of malignant pleural mesothelioma (MPM) has been reported among population groups with no documented professional exposure to asbestos fibres living in different geographic areas. This paper reviews existing data related to non occupational MPM including its occurrence in the province of Catania (Sicily, Italy).
An electronic search of literature related to non occupational MPM was performed including the year 2005.
Non occupational MPM in subjects living in areas contaminated by a variety of asbestos and non asbestos fibres has been well documented through a number of epidemiologic studies including cases series, case-control studies, and a cohort study. In addition, the observation of familial clustering of MPM, suggests that genetic factors may play a role in the pathogenesis of this malignancy. The epidemiological evidence also suggests that MPM may occur as a result of the interaction between environmental carcinogens, genetic factors, and virus infection.
It is likely that genetic predisposition and non-occupational exposure to low doses of asbestos and asbestos-like fibres may concur to the development of malignant mesothelioma. However, additional epidemiological and laboratory studies are needed to further understand the relationship between environmental exposure and individual susceptibility to this malignancy.

Download full-text


Available from: Lucia Spicuzza, Jun 14, 2014
  • [Show abstract] [Hide abstract]
    ABSTRACT: The role of adenosine in allergic inflammation is unclear. This study investigated the effects of the non-selective adenosine receptor agonist, 5-N-ethylcarboxamidoadenosine (NECA), on immunized only and immunized and airway challenged mice. The adenosine receptor sub-type(s) mediating the NECA effects and the A(2A) receptor mRNA expression were also investigated. In mice that were only immunized, intranasal NECA (1 mM) administration caused a significant increase in bronchoalveolar lavage total cell count (TCC), neutrophils and eosinophils (>1.5-, >6 and >60-fold, respectively). Two and four intranasal ovalbumin (OVA) challenges induced a significant (P < 0.05) increase in TCC (>2.1- and >4-fold, respectively) and eosinophils (>350- and >1700-fold, respectively). Real-time PCR analysis showed that the A(2A) receptor sub-type mRNA was significantly increased (P < 0.05) in the lung tissue of immunized mice following both two and four OVA challenges. NECA (0.3 mM) treatment caused a significant reduction in the increase induced by the two and four OVA challenges in the TCC by 46.1% and 56.6%, respectively, eosinophils by 70.1% and 75.6%, respectively, and in the A(2A) receptor sub-type mRNA by 43.2% and 41.0%, respectively. Treatment with the A(2A) receptor antagonist, 7-(2-phenylethyl)-5-amino-2-(2-furyl)-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine), SCH-58261, completely reversed both the NECA-mediated reduction in TCC and eosinophilia. Moreover, OVA challenge of immunized mice, over 2 consecutive days, resulted in a significant (P < 0.05) increase in TCC (4.5-fold) and eosinophils (>2000-fold) that was detected 72 h later. NECA (0.3 mM) treatment, at 24 and 48 h post OVA challenge, significantly reduced the increase in both TCC and eosinophils by 45.0% and 74.8%, respectively. Our data show that in immunized, but not OVA-challenged mice, high dose of NECA (1 mM) induces an inflammatory airway response. In contrast, in models of inflammation, NECA, at mainly 0.3 mM, induces a significant anti-inflammatory effect when administered prior to the induction of airway inflammation or therapeutically following its establishment. The data also indicate that the anti-inflammatory action of NECA seems to be mediated via the A(2A) receptor sub-type and hence the use of selective A(2A) receptor agonists as potential therapeutic agents in the treatment of inflammatory diseases such as asthma should be investigated further.
    Pulmonary Pharmacology &amp Therapeutics 12/2008; 22(3):243-52. DOI:10.1016/j.pupt.2008.12.012 · 2.94 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In questo volume vengono ricostruite le fasi principali che hanno caratterizzato l'attività svolta dall'Istituto Superiore di Sanità sulle tematiche legate all'amianto. Viene così ripercorso un cammino durato oltre trent'anni che ha visto l'Istituto impegnato in molteplici ambiti: dalla ricerca sperimentale in laboratorio a quella epidemiologica sul campo; dalla formazione e specializzazione di operatori del Servizio Sanitario Nazionale coinvolti in attività di controllo e prevenzione alla collaborazione con le istituzioni impegnate a livello internazionale, nazionale e regionale nella individuazione delle fonti di amianto poco o per nulla conosciute, nella loro divulgazione e nella sensibilizzazione dei gruppi di popolazione a rischio. Il volume sottolinea altresì il contributo di esperienze e conoscenze fornito dall'Istituto alle Commissioni parlamentari di Camera e Senato, sia in occasione di 27 marzo 1992 n. 257 "Norme relative alla cessazione dell'impiego dell'amianto". ha lo scopo di documentare, attraverso le testimonianze sia materiali (strumenti pubblica italiana. l'attività dell'Istituto Superiore di Sanità negli anni 1980-2012 Quaderno 9 Le problematiche scientifi co-sanitarie correlate all'amianto: l'attività dell'ISS negli anni 1980-2012
    10/2012; , ISBN: 978-88-97498-03-2
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Human malignant pleural mesothelioma (MPM) is an aggressive cancer due to former asbestos exposure with little knowledge about prognostic factors of outcome and resistance to conventional therapy. BRCA1-associated protein 1 (BAP1) is a tumor suppressor gene that is frequently lost in MPM. Germline mutations of BAP1 predispose to several different tumors including malignant mesothelioma. Our study aimed to clarify if asbestos exposure has an influence on BAP1 expression and if BAP1 expression could be used as a prognostic factor of outcome. An immunohistochemical staining for BAP1 was performed on 123 MPM tissue samples and the expression levels have been correlated with asbestos exposure and overall survival time. BAP1 expression was not associated with asbestos exposure but we detected a significant effect of BAP1 expression on overall survival time - the higher the BAP1 expression (non-mutated BAP1), the shorter the overall survival. BAP1 mutation has been linked to non-asbestos induced familial mesotheliomas, which usually belong to the long survivor group and BAP1 is most probably functioning differently than in sporadic cases. Further investigations need to be performed to characterize the BAP1 mutations and to identify the BAP1 downstream targets in MPM.
    Pathology & Oncology Research 08/2013; 20(1). DOI:10.1007/s12253-013-9677-2 · 1.86 Impact Factor
Show more